ドライアイ症候群治療の市場規模、シェア＆動向分析レポート：タイプ別（蒸発性、房水欠乏性）、製品別、剤形別、販売チャネル別、流通チャネル別、地域別、セグメント別予測、2022年～2030年

ドライアイ症候群治療市場の成長・動向

Grand View Research, Inc.の最新レポートによると、世界のドライアイ症候群治療市場規模は2030年までに74億3000万米ドルに達し、2022年から2030年までCAGR4.31%で拡大すると予測されています。市場の成長は、スクリーン使用の増加、老年人口の増加、眼疾患の有病率の上昇などの要因に起因しています。

画面付きデバイスの使用頻度の増加、コンピューターの使用急増、瞬きの回数の減少などが、蒸発性ドライアイ症候群の世界の成長につながっています。例えば、2021年のFrontiers Journalによると、パンデミック前と比較すると、COVID-19のパンデミック時に成人のスクリーンの使用率が60～80％増加しています。スクリーンに触れることで、まばたきの回数が66％減少するため、涙の蒸発がエスカレートし、ドライアイにつながるのだそうです。

医療用医薬品の普及率が極めて低いため、マーケットプレースでは一般用医薬品が主流となっています。例えば、ドライアイと診断された人のうち、処方箋による治療を受けている人はわずか10％であり、75％の人は処方箋による治療を受けたことがありません。しかし、ドライアイ症候群と診断された患者数は、眼科医全体の5～35％を占めています。

さらに、XiidraやRestasisなどの既存製品は、効果が現れるまでに数カ月から数週間かかるという問題があります。また、眼科医によると、これらの製品には忍容性の問題があり、故障率は50%にも上ると言われています。このことは、市場にアンメット・ニーズが存在することを示しており、今後数年間に発売が予定されているパイプライン製品にとって有利な機会を生み出すと予想されます。さらに、医薬品に関連する規制は、市場全体の成長をさらに妨げています。例えば、2020年には、規制当局がXiidraの使用に大きな異議を唱えた後、ノバルティスは欧州でXiidraの使用を自主的に撤回しなければなりませんでした。

主要企業によるイノベーションと戦略的イニシアティブが市場を牽引しています。新製品の発売は、プレーヤーが用いている一般的な戦略です。例えば、2021年10月、Oyster Point Pharma社のTyrvaya（バレニクリン溶液）点鼻薬は、代替治療アプローチとしてFDAに承認されました。

ドライアイ症候群治療市場のレポートハイライト

タイプ別では、有病率の増加とスクリーンタイムの増加により、蒸発性ドライアイ症候群が2021年に最大のシェアを占めた

剤形別では、入手のしやすさと点眼投与への嗜好の高まりから、点眼薬が2021年に最大の売上シェアを占めました。

薬剤別では、ドライアイ治療の処方箋薬として高い採用率を誇るRestasisが2021年に最大の市場シェアを獲得

販売チャネル別では、利便性の高さからオンライン薬局を選択する消費者が増えており、予測期間中にオンライン薬局が最も速い速度で成長すると予想される

2021年の市場規模は、有病率の高さ、認知度の高さ、治療率の高さから北米が圧倒的に多い

目次

第1章 調査手法と範囲

• 市場セグメンテーション
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
    • アプローチ3：トップダウンアプローチを使用した国別の市場推定
• 世界市場：CAGR計算
• 調査の仮定
• 市場シェアの計算
• 二次情報一覧
• 目的
• 略語一覧

第2章 エグゼクティブサマリー

• 市場概要

第3章 ドライアイ症候群治療市場- 業界の展望

• 市場系列の見通し
  • 親市場系統の見通し
  • 関連/補助的な市場の見通し
• 浸透と成長の見通しのマッピング
• 市場力学
  • 市場促進要因
    • 高齢者人口の増加
    • 眼関連疾患の有病率の増加
    • ドライアイ症候群に対する意識の高まり
    • コンタクトレンズの使用の増加
  • 市場抑制分析
    • 熟練した眼科医の不足
• SWOT分析、要因別（政治と法律、経済と技術）
• 業界分析- ポーターの5つの力
• 規制シナリオ
• 主要取引と戦略的提携
  • 新製品の発売
  • 取得
  • 拡張
  • パートナーシップ

第4章 ドライアイ症候群治療市場：競合分析

• 主要な市場参加者別最近の動向と影響分析
  • アンソフ行列`
• 会社の分類
  • イノベーター
    • 市場の差別化要因
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2021年
• 上場企業
  • 競合ダッシュボード分析
• 民間企業
  • 主要新興企業一覧
• Regional Network Map
• Key Regional/Local Competitors

第5章 ドライアイ症候群治療市場分析：タイプスコープ、2018年から2030年（収益、100万米ドル）

• ドライアイ症候群治療市場：タイプの変動分析
• 蒸発性ドライアイ症候群
• 房水欠乏ドライアイ症候群

第6章 ドライアイ症候群治療市場分析：医薬品の範囲、2018年から2030年（収益、100万米ドル）

• ドライアイ症候群治療市場：薬物変動分析
• レスタシス
• シイドラ
• セクア
• アイスヴィス
• ティルヴァヤ
• その他

第7章 ドライアイ症候群治療市場分析：製品範囲、2018年から2030年（収益、100万米ドル）

• ドライアイ症候群治療市場：製品変動分析
• シクロスポリン
• 局所コルチコステロイド
• 人工涙液
• 涙点プラグ
  • 取り外し可能
  • 溶ける
• オーラルオメガサプリメント
• その他

第8章 ドライアイ症候群治療市場分析：剤形範囲、2018年から2030年（収益、100万米ドル）

• ドライアイ治療市場：剤形変動分析
• ゲル
• アイソリューション
• カプセル・錠剤
• 目薬
• 軟膏

第9章 ドライアイ症候群治療市場分析：販売チャネルの範囲、2018年から2030年（収益、100万米ドル）

• ドライアイ治療市場：販路変動分析
• 処方
• OTC

第10章 ドライアイ症候群治療市場分析：流通チャネルの範囲、2018年から2030年（収益、100万米ドル）

• ドライアイ症候群治療市場：流通経路の変動分析
• 病院薬局
• オンライン薬局
• 小売薬局

第11章 ドライアイ症候群治療市場分析、地域範囲、2018年から2030年、（収益、100万米ドル）

• 国別の市場シェア分析、2021年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 ドライアイ症候群治療市場：企業プロファイリング

• 企業プロファイル
  • Novartis AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AbbVie, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Sun Pharmaceutical Industries Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Santen Pharmaceutical Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AFT Pharmaceuticals
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Johnson &Johnson Services, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Otsuka Pharmaceutical Co., Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • OASIS Medical.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Oyster Point Pharma, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Bausch &Lomb
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• 1. List of Secondary Sources
• 2. List of Abbreviations
• 3. Incidence of Diseases
• 4. Global Dry Eye Syndrome Treatment Market, By Region, 2018 - 2030 (USD Million)
• 5. Global Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 6. Global Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 7. Global Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 8. Global Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 9. Global Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 10. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 11. North America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• 12. North America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 13. North America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 14. North America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 15. North America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 16. North America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 17. North America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 18. U.S. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 19. U.S. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 20. U.S. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 21. U.S. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 22. U.S. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 23. U.S. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 24. Canada Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 25. Canada Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 26. Canada Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 27. Canada Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 28. Canada Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 29. Canada Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 30. Europe Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• 31. Europe Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 32. Europe Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 33. Europe Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 34. Europe Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 35. Europe Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 36. Germany Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 37. Germany Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 38. Germany Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 39. Germany Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 40. Germany Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 41. Germany Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 42. U.K. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 43. U.K. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 44. U.K. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 45. U.K. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 46. U.K. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 47. U.K. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 48. France Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 49. France Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 50. France Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 51. France Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 52. France Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 53. France Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 54. Italy Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 55. Italy Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 56. Italy Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 57. Italy Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 58. Italy Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 59. Italy Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 60. Spain Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 61. Spain Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 62. Spain Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 63. Spain Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 64. Spain Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 65. Spain Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 66. Asia Pacific Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• 67. Asia Pacific Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 68. Asia Pacific Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 69. Asia Pacific Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 70. Asia Pacific Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 71. Asia Pacific Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 72. Asia Pacific Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 73. Japan Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 74. Japan Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 75. Japan Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 76. Japan Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 77. Japan Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 78. Japan Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 79. China Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 80. China Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 81. China Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 82. China Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 83. China Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 84. China Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 85. India Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 86. India Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 87. India Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 88. India Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 89. India Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 90. India Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 91. South Korea Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 92. South Korea Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 93. South Korea Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 94. South Korea Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 95. South Korea Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 96. South Korea Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 97. Australia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 98. Australia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 99. Australia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 100. Australia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 101. Australia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 102. Australia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 103. Latin America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• 104. Latin America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 105. Latin America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 106. Latin America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 107. Latin America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 108. Latin America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 109. Latin America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 110. Brazil Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 111. Brazil Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 112. Brazil Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 113. Brazil Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 114. Brazil Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 115. Brazil Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 116. Mexico Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 117. Mexico Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 118. Mexico Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 119. Mexico Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 120. Mexico Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 121. Mexico Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 122. Argentina Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 123. Argentina Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 124. Argentina Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 125. Argentina Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 126. Argentina Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 127. Argentina Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 128. Middle East & Africa Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• 129. Middle East & Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 130. Middle East & Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 131. Middle East & Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 132. Middle East & Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 133. Middle East & Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 134. Middle East & Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 135. Saudi Arabia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 136. Saudi Arabia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 137. Saudi Arabia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 138. Saudi Arabia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 139. Saudi Arabia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 140. Saudi Arabia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 141. South Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 142. South Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 143. South Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 144. South Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 145. South Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 146. South Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• 147. UAE Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• 148. UAE Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• 149. UAE Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• 150. UAE Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• 151. UAE Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• 152. UAE Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

• 1. Market Research Process
• 2. Information Procurement
• 3. Primary Research Pattern
• 4. Market Research Approaches
• 5. Value Chain-Based Sizing & Forecasting
• 6. Market Formulation & Validation
• 7. Dry Eye Syndrome Treatment Market Segmentation
• 8. Market Driver Relevance Analysis (Current & Future Impact)
• 9. Market Restraint Relevance Analysis (Current & Future Impact)
• 10. Market Challenge Relevance Analysis (Current & Future Impact)
• 11. Penetration & Growth Prospect Mapping
• 12. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• 13. Porter's Five Forces Analysis
• 14. Market Penetration & Growth Prospect Mapping
• 15. Dry eye syndrome treatment market: Type outlook and key takeaways
• 16. Dry eye syndrome treatment market: Type movement analysis & market share 2021 & 2030
• 17. Evaporative dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
• 18. Aqueous dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
• 19. Dry eye syndrome treatment market: Drug outlook and key takeaways
• 20. Dry eye syndrome treatment market: Drug movement analysis & market share 2021 & 2030
• 21. Restasis market estimates and forecast, 2018 - 2030 (USD Million)
• 22. Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
• 23. Cequa market estimates and forecast, 2018 - 2030 (USD Million)
• 24. Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
• 25. Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
• 26. Others market estimates and forecast, 2018 - 2030 (USD Million)
• 27. Dry eye syndrome treatment market: Product outlook and key takeaways
• 28. Dry eye syndrome treatment market: Product movement analysis & market share 2021 & 2030
• 29. Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
• 30. Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
• 31. Artificial tears market estimates and forecast, 2018 - 2030 (USD Million)
• 32. Punctal plugs market estimates and forecast, 2018 - 2030 (USD Million)
• 33. Oral omega supplements market estimates and forecast, 2018 - 2030 (USD Million)
• 34. Others market estimates and forecast, 2018 - 2030 (USD Million)
• 35. Dry eye syndrome treatment market: Dosage form outlook and key takeaways
• 36. Dry eye syndrome treatment market: Dosage form movement analysis & market share 2021 & 2030
• 37. Gels market estimates and forecast, 2018 - 2030 (USD Million)
• 38. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
• 39. Capsules and tablets market estimates and forecast, 2018 - 2030 (USD Million)
• 40. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
• 41. Ointments market estimates and forecast, 2018 - 2030 (USD Million)
• 42. Dry eye syndrome treatment market: Sales channel outlook and key takeaways
• 43. Dry eye syndrome treatment market: Sales channel movement analysis & market share 2021 & 2030
• 44. Prescription market estimates and forecast, 2018 - 2030 (USD Million)
• 45. OTC market estimates and forecast, 2018 - 2030 (USD Million)
• 46. Dry eye syndrome treatment market: Distribution channel outlook and key takeaways
• 47. Dry eye syndrome treatment market: Distribution channel movement analysis & market share 2021 & 2030
• 48. Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 49. Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 50. Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 51. Regional Marketplace: Key Takeaways
• 52. Regional Outlook, 2018 & 2030
• 53. Regional Market Dashboard
• 54. Regional Market Place: Key Takeaways
• 55. North America, SWOT Analysis
• 56. Europe, SWOT Analysis
• 57. Asia Pacific, SWOT Analysis
• 58. Latin America, SWOT Analysis
• 59. MEA, SWOT Analysis
• 60. North America
• 61. North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 62. U.S.
• 63. U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 64. Canada
• 65. Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 66. Europe
• 67. Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 68. U.K.
• 69. U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 70. Germany
• 71. Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 72. France
• 73. France Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 74. Italy
• 75. Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 76. Spain
• 77. Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 78. Asia Pacific
• 79. Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 80. Japan
• 81. Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 82. China
• 83. China Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 84. India
• 85. India Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 86. Australia
• 87. Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 88. South Korea
• 89. South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 90. Latin America
• 91. Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 92. Brazil
• 93. Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 94. Mexico
• 95. Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 96. Argentina
• 97. Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 98. MEA
• 99. MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 100. South Africa
• 101. South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 102. Saudi Arabia
• 103. Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 104. UAE
• 105. UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
• 106. Strategy Mapping

Dry Eye Syndrome Treatment Market Growth & Trends:

The global dry eye syndrome treatment market size is expected to reach USD 7.43 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.31% from 2022 to 2030. The growth of the market is attributed to factors such as the increasing use of screens, the rising geriatric population, and a heightened prevalence of eye diseases.

The heightened use of devices with a screen, surging use of computers, and a decreased number of blinks are subsequently leading to the growth of evaporative dry eye syndrome globally. For instance, as per Frontiers Journal in 2021, when compared to pre-pandemic years, the use of screens has increased by 60-80% in adults during the COVID-19 pandemic. The exposure to the screen leads to a 66% decreased blinking rate, thus escalating the evaporation of tears and leading to dry eye disease.

Over-the-counter (OTC) products predominate the marketplace due to the extremely low acceptance of prescription products. For instance, only 10% of the diagnosed population is on prescription therapies, while 75% of the population has never tried prescription therapy. However, the number of patients diagnosed with dry eye syndrome accounts for 5-35% of overall ophthalmologist visits.

Moreover, existing products such as Xiidra and Restasis take months or weeks to demonstrate effects. In addition, as per eye consultants, these products have tolerability issues and a failure rate of as high as 50%. This depicts an unmet need in the market and is anticipated to create a lucrative opportunity for pipeline products expected to launch in the upcoming years. Moreover, regulations associated with the drugs further hamper the growth of the overall market. For instance, in 2020, Novartis had to voluntarily withdraw the use of Xiidra in Europe after regulators raised major objections to its use of xiidra.

Innovations and strategic initiatives by key players are driving the market. New product launch is a common strategy being used by the players. For instance, in October 2021, Tyrvaya (varenicline solution) nasal spray by Oyster Point Pharma was approved by the FDA as an alternative treatment approach.

Dry Eye Syndrome Treatment Market Report Highlights:

• By type, evaporative dry eye syndrome held the largest share in 2021 owing to the increasing prevalence of the condition and heightened screen time

• Based on dosage form, eye drops held the largest revenue share in 2021 owing to easy availability as well as increased preference for eye drop administration of the product

• By drug, Restasis held the largest market share in 2021 owing to its high adoption as a prescription drug for dry eye treatment

• Based on distribution channel, online pharmacies are expected to grow at the fastest rate over the forecast period due to the increased consumer preference for online pharmacies owing to the convenience

• North America dominated the market in 2021 due to the high prevalence of the disease, surging awareness, and enhanced treatment rate

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
    • 1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 Market Share Calculations
• 1.10 List of Secondary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Summary

Chapter 3 Dry Eye Syndrome Treatment Market - Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Lineage Outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Drivers
    • 3.3.1.1 Growing geriatric population
    • 3.3.1.2 Increasing prevalence of eye-related diseases
    • 3.3.1.3 Growth in awareness of dry eye syndrome
    • 3.3.1.4 Increasing use of contact lenses
  • 3.3.2 Market restraint Analysis
    • 3.3.2.1 Lack of skilled ophthalmologists
• 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• 3.5 Industry Analysis - Porter's Five Forces
• 3.6 Regulatory Scenario
• 3.7 Major Deals & Strategic Alliances
  • 3.7.1 New Product Launch
  • 3.7.2 Acquisition
  • 3.7.3 Expansion
  • 3.7.4 Partnerships

Chapter 4 Dry Eye Syndrome Treatment Market: Competitive Analysis

• 4.1 Recent Developments and Impact Analysis, by Key Market Participants
  • 4.1.1 Ansoff matrix`
• 4.2 Company Categorization
  • 4.2.1 Innovators
    • 4.2.1.1 Market Differentiators
• 4.3 Vendor Landscape
  • 4.3.1 List of key distributors and channel partners
  • 4.3.2 Key customers
  • 4.3.3 Key company market share analysis, 2021
• 4.4 Public Companies
  • 4.4.1 Competitive dashboard analysis
• 4.5 Private Companies
  • 4.5.1 List of key emerging companies
• 4.6 Regional Network Map
• 4.7 Key Regional/Local Competitors

Chapter 5 Dry Eye Syndrome Treatment Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)

• 5.1 Dry Eye Syndrome Treatment Market: Type Movement Analysis
• 5.2 Evaporative Dry Eye Syndrome
  • 5.2.1 Evaporative dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)
• 5.3 Aqueous Deficient Dry Eye Syndrome
  • 5.3.1 Aqueous deficient dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Dry Eye Syndrome Treatment Market Analysis: Drug Scope, 2018 - 2030 (Revenue, USD Million)

• 6.1 Dry Eye Syndrome Treatment Market: Drug Movement Analysis
• 6.2 Restasis
  • 6.2.1 Restasis market estimates and forecast, 2018 - 2030 (USD Million)
• 6.3 Xiidra
  • 6.3.1 Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4 Cequa
  • 6.4.1 Cequa market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5 Eysuvis
  • 6.5.1 Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6 Tyrvaya
  • 6.6.1 Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7 Others
  • 6.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Dry Eye Syndrome Treatment Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)

• 7.1 Dry Eye Syndrome Treatment Market: Product Movement Analysis
• 7.2 Cyclosporine
  • 7.2.1 Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
• 7.3 Topical Corticosteroids
  • 7.3.1 Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4 Artificial Tears
  • 7.4.1 Artificial Tears market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5 Punctal Plugs
  • 7.5.1 Punctal Plugs market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.2 Removable
    • 7.5.2.1 Removable market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3 Dissolvable
    • 7.5.3.1 Dissolvable market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6 Oral Omega Supplements
  • 7.6.1 Oral Omega Supplements market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7 Others
  • 7.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Dry Eye Syndrome Treatment Market Analysis: Dosage Form Scope, 2018 - 2030 (Revenue, USD Million)

• 8.1 Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
• 8.2 Gels
  • 8.2.1 Gels market estimates and forecast, 2018 - 2030 (USD Million)
• 8.3 Eye Solution
  • 8.3.1 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4 Capsules & Tablets
  • 8.4.1 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Million)
• 8.5 Eye Drops
  • 8.5.1 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
• 8.6 Ointments
  • 8.6.1 Ointments market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Dry Eye Syndrome Treatment Market Analysis: Sales Channel Scope, 2018 - 2030 (Revenue, USD Million)

• 9.1 Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
• 9.2 Prescription
  • 9.2.1 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
• 9.3 OTC
  • 9.3.1 OTC market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Dry Eye Syndrome Treatment Market Analysis: Distribution Channel Scope, 2018 - 2030 (Revenue, USD Million)

• 10.1 Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
• 10.2 Hospital Pharmacies
  • 10.2.1 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 10.3 Online Pharmacies
  • 10.3.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 10.4 Retail Pharmacies
  • 10.4.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 11 Dry Eye Syndrome Treatment Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)

• 11.1 Market Share Analysis by Country, 2021 & 2030
  • 11.1.1 North America
    • 11.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.1.2 U.S.
    • 11.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.1.3 Canada
    • 11.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 11.1.2 Europe
    • 11.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2.2 U.K.
    • 11.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2.3 Germany
    • 11.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2.4 France
    • 11.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2.5 Italy
    • 11.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2.6 Spain
    • 11.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 11.1.3 Asia Pacific
    • 11.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3.2 Japan
    • 11.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3.3 China
    • 11.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3.4 India
    • 11.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3.5 South Korea
    • 11.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3.6 Australia
    • 11.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 11.1.4 Latin America
    • 11.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.4.2 Brazil
    • 11.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.4.3 Mexico
    • 11.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.4.4 Argentina
    • 11.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 11.1.5 Middle East and Africa
    • 11.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.5.2 South Africa
    • 11.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.5.3 Saudi Arabia
    • 11.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.5.4 UAE
    • 11.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 12 Dry Eye Syndrome Treatment Market: Company Profiling

• 12.1 Company Profiles
  • 12.1.1 Novartis AG
    • 12.1.1.1 Company overview
    • 12.1.1.2 Financial performance
    • 12.1.1.3 Product benchmarking
    • 12.1.1.4 Strategic initiatives
  • 12.1.2 AbbVie, Inc.
    • 12.1.2.1 Company overview
    • 12.1.2.2 Financial performance
    • 12.1.2.3 Product benchmarking
    • 12.1.2.4 Strategic initiatives
  • 12.1.3 Sun Pharmaceutical Industries Ltd.
    • 12.1.3.1 Company overview
    • 12.1.3.2 Financial performance
    • 12.1.3.3 Product benchmarking
    • 12.1.3.4 Strategic initiatives
  • 12.1.4 Santen Pharmaceutical Co., Ltd.
    • 12.1.4.1 Company overview
    • 12.1.4.2 Financial performance
    • 12.1.4.3 Product benchmarking
    • 12.1.4.4 Strategic initiatives
  • 12.1.5 AFT Pharmaceuticals
    • 12.1.5.1 Company overview
    • 12.1.5.2 Financial performance
    • 12.1.5.3 Product benchmarking
    • 12.1.5.4 Strategic initiatives
  • 12.1.6 Johnson & Johnson Services, Inc.
    • 12.1.6.1 Company overview
    • 12.1.6.2 Financial performance
    • 12.1.6.3 Product benchmarking
    • 12.1.6.4 Strategic initiatives
  • 12.1.7 Otsuka Pharmaceutical Co., Ltd.
    • 12.1.7.1 Company overview
    • 12.1.7.2 Financial performance
    • 12.1.7.3 Product benchmarking
    • 12.1.7.4 Strategic initiatives
  • 12.1.8 OASIS Medical.
    • 12.1.8.1 Company overview
    • 12.1.8.2 Financial performance
    • 12.1.8.3 Product benchmarking
    • 12.1.8.4 Strategic initiatives
  • 12.1.9 Oyster Point Pharma, Inc.
    • 12.1.9.1 Company overview
    • 12.1.9.2 Financial performance
    • 12.1.9.3 Product benchmarking
    • 12.1.9.4 Strategic initiatives
  • 12.1.10 Bausch & Lomb
    • 12.1.10.1 Company overview
    • 12.1.10.2 Financial performance
    • 12.1.10.3 Product benchmarking
    • 12.1.10.4 Strategic initiatives